# Freshpet, Inc.: financial statements, quarterly

FRPT · Nasdaq · CIK 1611647 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/frpt.md) · [Financials](/companies/frpt/financials.md) · [Filings](/companies/frpt/filings.md) · [Insiders](/companies/frpt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/frpt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [201](/filings/0001611647-24-000019.md) | [215 d](/filings/0001611647-26-000006.md) | [224](/filings/0001611647-25-000013.md) | [235](/filings/0001611647-25-000021.md) | [253](/filings/0001611647-25-000030.md) | [263 d](/filings/0001611647-26-000006.md) | [263](/filings/0001611647-26-000012.md) | [265](/filings/0001611647-26-000018.md) | [289](/filings/0001611647-25-000030.md) | [285 d](/filings/0001611647-26-000006.md) | [298](/filings/0001611647-26-000012.md) | [306](/filings/0001611647-26-000018.md) |
| Cost of revenue | $m | [134](/filings/0001611647-24-000019.md) | [141 d](/filings/0001611647-26-000006.md) | [136](/filings/0001611647-25-000013.md) | [141](/filings/0001611647-25-000021.md) | [151](/filings/0001611647-25-000030.md) | [151 d](/filings/0001611647-26-000006.md) | [159](/filings/0001611647-26-000012.md) | [156](/filings/0001611647-26-000018.md) | [175](/filings/0001611647-25-000030.md) | [162 d](/filings/0001611647-26-000006.md) | [177](/filings/0001611647-26-000012.md) | [177](/filings/0001611647-26-000018.md) |
| Gross profit | $m | [66.3](/filings/0001611647-24-000019.md) | [74.6 d](/filings/0001611647-26-000006.md) | [88.2](/filings/0001611647-25-000013.md) | [94.0](/filings/0001611647-25-000021.md) | [102](/filings/0001611647-25-000030.md) | [112 d](/filings/0001611647-26-000006.md) | [104](/filings/0001611647-26-000012.md) | [108](/filings/0001611647-26-000018.md) | [114](/filings/0001611647-25-000030.md) | [123 d](/filings/0001611647-26-000006.md) | [121](/filings/0001611647-26-000012.md) | [129](/filings/0001611647-26-000018.md) |
| Selling, general and administrative | $m | [73.4](/filings/0001611647-24-000019.md) | [59.7 d](/filings/0001611647-26-000006.md) | [79.7](/filings/0001611647-25-000013.md) | [95.7](/filings/0001611647-25-000021.md) | [90.3](/filings/0001611647-25-000030.md) | [92.2 d](/filings/0001611647-26-000006.md) | [115](/filings/0001611647-26-000012.md) | [90.4](/filings/0001611647-26-000018.md) | [89.3](/filings/0001611647-25-000030.md) | [79.0 d](/filings/0001611647-26-000006.md) | [116](/filings/0001611647-26-000012.md) | [107](/filings/0001611647-26-000018.md) |
| Operating income | $m | [(7.1)](/filings/0001611647-24-000019.md) | [14.9 d](/filings/0001611647-26-000006.md) | [8.5](/filings/0001611647-25-000013.md) | [(1.8)](/filings/0001611647-25-000021.md) | [11.9](/filings/0001611647-25-000030.md) | [19.4 d](/filings/0001611647-26-000006.md) | [(11.5)](/filings/0001611647-26-000012.md) | [17.8](/filings/0001611647-26-000018.md) | [24.9](/filings/0001611647-25-000030.md) | [44.5 d](/filings/0001611647-26-000006.md) | [4.3](/filings/0001611647-26-000012.md) | [21.7](/filings/0001611647-26-000018.md) |
| Interest expense | $m | [4.1](/filings/0001437749-23-030394.md) | [3.4 d](/filings/0001437749-24-005542.md) | [3.1](/filings/0001437749-24-014824.md) | [2.8](/filings/0001611647-25-000021.md) | [2.9](/filings/0001611647-25-000030.md) | [3.5 d](/filings/0001611647-26-000006.md) | [3.5](/filings/0001611647-26-000012.md) | [3.7](/filings/0001611647-26-000018.md) | [3.6](/filings/0001611647-25-000030.md) | [3.4 d](/filings/0001611647-26-000006.md) | [3.6](/filings/0001611647-26-000012.md) | [3.5](/filings/0001611647-26-000018.md) |
| Income tax | $m | [0.1](/filings/0001611647-24-000019.md) | [0.0 d](/filings/0001611647-26-000006.md) | [0.1](/filings/0001611647-25-000013.md) | [0.1](/filings/0001611647-25-000021.md) | [0.1](/filings/0001611647-25-000030.md) | [0.4 d](/filings/0001611647-26-000006.md) | [0.1](/filings/0001611647-26-000012.md) | [(0.1)](/filings/0001611647-26-000018.md) | [(78.0)](/filings/0001611647-25-000030.md) | [9.6 d](/filings/0001611647-26-000006.md) | [17.1](/filings/0001611647-26-000012.md) | [6.1](/filings/0001611647-26-000018.md) |
| Net income | $m | [(7.2)](/filings/0001611647-24-000019.md) | [15.3 d](/filings/0001611647-26-000006.md) | [18.6](/filings/0001611647-25-000013.md) | [(1.7)](/filings/0001611647-25-000021.md) | [11.9](/filings/0001611647-25-000030.md) | [18.1 d](/filings/0001611647-26-000006.md) | [(12.7)](/filings/0001611647-26-000012.md) | [16.4](/filings/0001611647-26-000018.md) | [102](/filings/0001611647-25-000030.md) | [33.8 d](/filings/0001611647-26-000006.md) | [48.5](/filings/0001611647-26-000012.md) | [19.5](/filings/0001611647-26-000018.md) |
| Diluted EPS | $ per share | [(0.15)](/filings/0001611647-24-000019.md) | not reported | [0.37](/filings/0001611647-25-000013.md) | [(0.03)](/filings/0001611647-25-000021.md) | [0.24](/filings/0001611647-25-000030.md) | not reported | [(0.26)](/filings/0001611647-26-000012.md) | [0.33](/filings/0001611647-26-000018.md) | [1.86](/filings/0001611647-25-000030.md) | not reported | [0.91](/filings/0001611647-26-000012.md) | [0.39](/filings/0001611647-26-000018.md) |
| Basic EPS | $ per share | [(0.15)](/filings/0001611647-24-000019.md) | not reported | [0.38](/filings/0001611647-25-000013.md) | [(0.03)](/filings/0001611647-25-000021.md) | [0.25](/filings/0001611647-25-000030.md) | not reported | [(0.26)](/filings/0001611647-26-000012.md) | [0.34](/filings/0001611647-26-000018.md) | [2.08](/filings/0001611647-25-000030.md) | not reported | [0.99](/filings/0001611647-26-000012.md) | [0.40](/filings/0001611647-26-000018.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [338](/filings/0001437749-23-030394.md) | [297](/filings/0001611647-25-000007.md) | [258](/filings/0001437749-24-014824.md) | [252](/filings/0001611647-24-000011.md) | [275](/filings/0001611647-24-000019.md) | [269](/filings/0001611647-26-000006.md) | [244](/filings/0001611647-25-000013.md) | [244](/filings/0001611647-25-000021.md) | [275](/filings/0001611647-25-000030.md) | [278](/filings/0001611647-26-000018.md) | [381](/filings/0001611647-26-000012.md) | [351](/filings/0001611647-26-000018.md) |
| Current assets | $m | [462](/filings/0001437749-23-030394.md) | [427](/filings/0001611647-25-000007.md) | [407](/filings/0001437749-24-014824.md) | [405](/filings/0001611647-24-000011.md) | [421](/filings/0001611647-24-000019.md) | [437](/filings/0001611647-26-000006.md) | [405](/filings/0001611647-25-000013.md) | [409](/filings/0001611647-25-000021.md) | [424](/filings/0001611647-25-000030.md) | [436](/filings/0001611647-26-000018.md) | [542](/filings/0001611647-26-000012.md) | [517](/filings/0001611647-26-000018.md) |
| Total assets | $m | [1,444](/filings/0001437749-23-030394.md) | [1,464](/filings/0001611647-25-000007.md) | [1,481](/filings/0001437749-24-014824.md) | [1,506](/filings/0001611647-24-000011.md) | [1,532](/filings/0001611647-24-000019.md) | [1,575](/filings/0001611647-26-000006.md) | [1,559](/filings/0001611647-25-000013.md) | [1,647](/filings/0001611647-25-000021.md) | [1,746](/filings/0001611647-25-000030.md) | [1,778](/filings/0001611647-26-000018.md) | [1,839](/filings/0001611647-26-000012.md) | [1,812](/filings/0001611647-26-000018.md) |
| Current liabilities | $m | [83.8](/filings/0001437749-23-030394.md) | [89.2](/filings/0001611647-25-000007.md) | [81.9](/filings/0001437749-24-014824.md) | [90.0](/filings/0001611647-24-000011.md) | [89.2](/filings/0001611647-24-000019.md) | [98.9](/filings/0001611647-26-000006.md) | [82.6](/filings/0001611647-25-000013.md) | [85.0](/filings/0001611647-25-000021.md) | [76.7](/filings/0001611647-25-000030.md) | [78.6](/filings/0001611647-26-000018.md) | [87.6](/filings/0001611647-26-000012.md) | [85.5](/filings/0001611647-26-000018.md) |
| Total liabilities | $m | [506](/filings/0001437749-23-030394.md) | [511](/filings/0001611647-25-000007.md) | [503](/filings/0001437749-24-014824.md) | [511](/filings/0001611647-24-000011.md) | [510](/filings/0001611647-24-000019.md) | [520](/filings/0001611647-26-000006.md) | [510](/filings/0001611647-25-000013.md) | [576](/filings/0001611647-25-000021.md) | [567](/filings/0001611647-25-000030.md) | [569](/filings/0001611647-26-000018.md) | [577](/filings/0001611647-26-000012.md) | [575](/filings/0001611647-26-000018.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [939](/filings/0001611647-24-000019.md) | [953](/filings/0001611647-26-000006.md) | [978](/filings/0001611647-25-000021.md) | [996](/filings/0001611647-25-000030.md) | [1,021](/filings/0001611647-25-000030.md) | [1,055](/filings/0001611647-26-000018.md) | [1,049](/filings/0001611647-26-000018.md) | [1,072](/filings/0001611647-26-000018.md) | [1,178](/filings/0001611647-25-000030.md) | [1,209](/filings/0001611647-26-000018.md) | [1,262](/filings/0001611647-26-000018.md) | [1,238](/filings/0001611647-26-000018.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [39.2 d](/filings/0001611647-24-000019.md) | [37.0 d](/filings/0001611647-26-000006.md) | [5.4](/filings/0001611647-25-000013.md) | [42.4 d](/filings/0001611647-25-000021.md) | [56.1 d](/filings/0001611647-25-000030.md) | [50.4 d](/filings/0001611647-26-000006.md) | [4.8](/filings/0001611647-26-000012.md) | [33.9 d](/filings/0001611647-26-000018.md) | [66.8 d](/filings/0001611647-25-000030.md) | [55.1 d](/filings/0001611647-26-000006.md) | [40.3](/filings/0001611647-26-000012.md) | [44.4 d](/filings/0001611647-26-000018.md) |
| Capital expenditure | $m | [59.1 d](/filings/0001611647-24-000019.md) | [77.5 d](/filings/0001611647-26-000006.md) | [46.5](/filings/0001611647-25-000013.md) | [48.3 d](/filings/0001611647-25-000021.md) | [34.0 d](/filings/0001611647-25-000030.md) | [58.3 d](/filings/0001611647-26-000006.md) | [26.5](/filings/0001611647-26-000012.md) | [33.4 d](/filings/0001611647-26-000018.md) | [35.2 d](/filings/0001611647-25-000030.md) | [53.1 d](/filings/0001611647-26-000006.md) | [27.6](/filings/0001611647-26-000012.md) | [29.7 d](/filings/0001611647-26-000018.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [47.9](/filings/0001437749-23-030394.md) | [48.0](/filings/0001437749-24-014824.md) | [48.1](/filings/0001611647-24-000011.md) | [48.2](/filings/0001611647-24-000019.md) | [50.0](/filings/0001611647-25-000013.md) | [48.5](/filings/0001611647-25-000021.md) | [50.3](/filings/0001611647-25-000030.md) | [48.7](/filings/0001611647-26-000012.md) | [50.2](/filings/0001611647-26-000018.md) | [55.9](/filings/0001611647-25-000030.md) | [56.1](/filings/0001611647-26-000012.md) | [55.8](/filings/0001611647-26-000018.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 48,058,074 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001611647-26-000018.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.